Published in Ophthal Plast Reconstr Surg on September 20, 2007
Effectiveness of the lower eyelid suspension using fascia lata graft for the treatment of lagophthalmos due to facial paralysis. Biomed Res Int (2015) 0.75
Orbital Adherence Syndrome following the Use of Titanium Precontoured Orbital Mesh for the Reconstruction of Posttraumatic Orbital Floor Defects. Craniomaxillofac Trauma Reconstr (2016) 0.75
Tear trough deformity: different types of anatomy and treatment options. Postepy Dermatol Alergol (2016) 0.75
Autologous Fat Grafting for Treating Blepharoplasty-induced Lower Eyelid Retraction. Plast Reconstr Surg Glob Open (2016) 0.75
Minimally invasive surgery for thyroid eye disease. Indian J Ophthalmol (2015) 0.75
Intralesional triamcinolone acetonide injection for primary and recurrent chalazia: is it really effective? Ophthalmology (2005) 3.45
What causes eyelid bags? Analysis of 114 consecutive patients. Plast Reconstr Surg (2005) 3.06
Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol (2009) 2.97
Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study. Ophthalmology (2011) 2.86
Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology (2006) 2.80
Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. Ophthalmology (2009) 2.44
Comparing outcomes of enucleation and evisceration. Ophthalmology (2006) 2.30
Orbital exenteration: one size does not fit all. Am J Ophthalmol (2005) 2.20
External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center. Ophthalmology (2005) 2.16
The hydrogel lacrimal stent for dacryocystorhinostomy: preliminary experience. Ophthal Plast Reconstr Surg (2008) 2.01
Scleral necrosis secondary to nonabsorbable suture following ptosis surgery. Ophthal Plast Reconstr Surg (2013) 1.99
Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated hess screen. Ophthalmology (2006) 1.74
External (subciliary) vs internal (transconjunctival) involutional entropion repair. Am J Ophthalmol (2005) 1.58
Frontalis suspension for upper eyelid ptosis: evaluation of different surgical designs and suture material. Am J Ophthalmol (2005) 1.51
Transconjunctival Müller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy. Am J Ophthalmol (2005) 1.45
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J Immunol (2008) 1.45
Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy. Ophthalmology (2005) 1.44
Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy. Arch Ophthalmol (2012) 1.40
Congenitally enlarged extraocular muscles: can congenital thyroid eye disease exist in a euthyroid infant? Ophthal Plast Reconstr Surg (2006) 1.39
Orbital volume augmentation for late enophthalmos using the deep lateral wall. Arch Facial Plast Surg (2003) 1.38
Feasibility study of intraocular robotic surgery with the da Vinci surgical system. Retina (2008) 1.25
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid (2008) 1.21
Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol (2009) 1.20
Immunopathogenesis of thyroid eye disease: emerging paradigms. Surv Ophthalmol (2010) 1.11
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci (2008) 1.10
Local anesthesia in oculoplastic surgery: precautions and pitfalls. Arch Facial Plast Surg (2008) 1.09
Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab (2012) 1.08
Prevalence of asymmetric exophthalmos in Graves orbitopathy. Ophthal Plast Reconstr Surg (2004) 1.06
Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease. J Clin Endocrinol Metab (2011) 1.05
Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab. Clin Endocrinol (Oxf) (2011) 1.04
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab (2012) 1.01
Facial recontouring with autogenous fat. Facial Plast Surg (2004) 1.01
Endoscopic removal of nasoglabellar dermoid cysts. Ophthal Plast Reconstr Surg (2010) 1.00
Clinical manifestations of orbital mass lesions at the Jules Stein Eye Institute, 1999-2003. Ophthalmic Surg Lasers Imaging (2006) 0.99
External levator advancement vs Müller's muscle-conjunctival resection for correction of upper eyelid involutional ptosis. Am J Ophthalmol (2005) 0.98
Early versus late repair of orbital blowout fractures. Ophthalmic Surg Lasers Imaging (2009) 0.97
Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci U S A (2012) 0.97
Brow ptosis correction: a comparison of five techniques. Facial Plast Surg (2010) 0.96
Minimally invasive orbital decompression: local anesthesia and hand-carved bone. Arch Ophthalmol (2005) 0.96
Regional correlation of structure and function in glaucoma, using the Disc Damage Likelihood Scale, Heidelberg Retina Tomograph, and visual fields. Ophthalmology (2006) 0.96
Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines. J Biol Chem (2006) 0.95
Modified conjunctivodacryocystorhinostomy for upper lacrimal system obstruction. Arch Facial Plast Surg (2007) 0.94
Muller's muscle-conjunctival resection for correction of upper eyelid ptosis: relationship between phenylephrine testing and the amount of tissue resected with final eyelid position. Arch Facial Plast Surg (2007) 0.94
Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB. Invest Ophthalmol Vis Sci (2012) 0.94
"En-glove" lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid retraction surgery. Ophthal Plast Reconstr Surg (2011) 0.94
Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening. Am J Ophthalmol (2008) 0.93
PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One (2010) 0.93
Epidermoid cyst of the upper eyelid tarsal plate. Ophthal Plast Reconstr Surg (2008) 0.93
Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. J Endocrinol (2011) 0.93
Medial wall decompression for optic neuropathy but lateral wall decompression with fat removal for non vision-threatening indications. Am J Ophthalmol (2006) 0.93
Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy. Ophthalmic Surg Lasers Imaging (2006) 0.92
Autologous dermis graft at the time of evisceration or enucleation. Br J Ophthalmol (2007) 0.91
Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning. Ophthalmology (2005) 0.91
Diagnostic fundus autofluorescence patterns in achromatopsia. Am J Ophthalmol (2013) 0.90
Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab (2014) 0.90
Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease. J Neuroophthalmol (2007) 0.90
Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel "gold weight". Ophthal Plast Reconstr Surg (2009) 0.89
Rethinking orbital imaging establishing guidelines for interpreting orbital imaging studies and evaluating their predictive value in patients with orbital tumors. Ophthalmology (2005) 0.89
Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management. Saudi J Ophthalmol (2010) 0.89
Inferior rectus muscle transection: a cause of diplopia after non-penetrating orbital trauma. Graefes Arch Clin Exp Ophthalmol (2006) 0.89
Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology (2006) 0.88
The pathophysiology of thyroid eye disease. J Neuroophthalmol (2014) 0.88
Aesthetic lateral canthoplasty. Ophthal Plast Reconstr Surg (2010) 0.87
Phenotypic conservation in patients with X-linked retinitis pigmentosa caused by RPGR mutations. JAMA Ophthalmol (2013) 0.86
Orbital wall fracture repair using Seprafilm. Ophthal Plast Reconstr Surg (2009) 0.86
Optic neuropathy following endovascular coiling of an orbital varix. Orbit (2012) 0.86
Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy. Thyroid (2008) 0.85
Snip conjunctivoplasty for postoperative conjunctival chemosis. Arch Facial Plast Surg (2010) 0.85
Subperiosteal midface lift with or without a hard palate mucosal graft for correction of lower eyelid retraction. Ophthalmology (2006) 0.85
Peripunctal melanocytic nevus. Int Ophthalmol (2011) 0.84
Clinical phenotypes and prognostic full-field electroretinographic findings in Stargardt disease. Am J Ophthalmol (2012) 0.83
Advances in the management of thyroid eye disease. Int Ophthalmol Clin (2013) 0.83
Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy? Nat Rev Endocrinol (2011) 0.83
Endoscopic dacryocystorhinostomy in acute dacryocystitis: a multicenter case series. Orbit (2011) 0.83
Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. Am J Ophthalmol (2004) 0.83
Paediatric endoscopic endonasal dacryocystorhinostomy in congenital nasolacrimal duct obstruction. Graefes Arch Clin Exp Ophthalmol (2006) 0.82
Localized Intraorbital Castleman's disease: a case report. Orbit (2010) 0.82
Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17. PLoS One (2012) 0.81
Acute myelogenous leukaemia presenting as a conjunctival lesion and red eye. Acta Ophthalmol Scand (2002) 0.81
Nonsurgical management of congenital eyelid malpositions using hyaluronic Acid gel. Ophthal Plast Reconstr Surg (2009) 0.81
Dermatofibrosarcoma protuberans metastatic to the orbit. Arch Ophthalmol (2004) 0.80
Skin necrosis after calcium hydroxylapatite injection into the glabellar and nasolabial folds. Ophthal Plast Reconstr Surg (2009) 0.80
Reactivation of thyroid-associated orbitopathy after cataract surgery. Jpn J Ophthalmol (2009) 0.80
Acquired port wine stain of the upper eyelid after cluster headache. Ophthal Plast Reconstr Surg (2008) 0.80
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique. Arch Ophthalmol (2009) 0.79
Anterior filler displacement following injection of calcium hydroxylapatite gel (Radiesse) for anophthalmic orbital volume augmentation. Ophthal Plast Reconstr Surg (2012) 0.79